Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Using proximity extension proteomics assay to identify biomarkers associated with infarct size and ejection fraction after ST-elevation myocardial infarction

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Biochemical abnormalities among patients referred for celiac disease antibody blood testing in a primary health care setting

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Reduced levels of pulmonary surfactant in COVID-19 ARDS

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Chronic inflammation markers and cytokine-specific autoantibodies in Danish blood donors with restless legs syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Assessment of immunogenicity and drug activity in patient sera by flow-induced dispersion analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Moman A Mohammad
  • Sasha Koul
  • Anna Egerstedt
  • J Gustav Smith
  • Marko Noc
  • Irene Lang
  • Michael Holzer
  • Peter Clemmensen
  • Olof Gidlöf
  • Bernhard Metzler
  • Thomas Engstrøm
  • David Erlinge
View graph of relations

Plasma concentrations of many cardiovascular and inflammatory proteins are altered after ST-elevation myocardial infarction (STEMI) and may provide prognostic information. We conducted a large-scale proteomic analysis in patients with STEMI, correlating protein levels to infarct size and left ventricular ejection fraction (LVEF) determined with cardiac magnetic resonance imaging. We analysed 131 cardiovascular and inflammatory proteins using a multiplex proximity extension assay and blood samples obtained at baseline, 6, 24, and 96 h from the randomised clinical trial CHILL-MI. Cardiac magnetic resonance imaging data at 4 ± 2 days and 6 months were available as per trial protocol. Using a linear regression model with bootstrap resampling and false discovery rate adjustment we identified five proteins (ST2, interleukin-6, pentraxin-3, interleukin-10, renin, and myoglobin) with elevated values corresponding to larger infarct size or worse LVEF and four proteins (TNF-related apoptosis-inducing ligand, TNF-related activation induced cytokine, interleukin-16, and cystatin B) with values inversely related to LVEF and infarct size, concluding that among 131 circulating inflammatory and cardiovascular proteins in the acute and sub-acute phase of STEMI, nine showed a relationship with infarct size and LVEF post-STEMI, with IL-6 and ST2 exhibiting the strongest association.

Original languageEnglish
JournalScientific Reports
Volume10
Issue number1
Pages (from-to)18663
ISSN2045-2322
DOIs
Publication statusPublished - 29 Oct 2020

ID: 62332473